These insights highlight the potential role of autoantibodies affecting the NPB-NPBWR1 signaling system in social behavior, suggesting its potential contribution to the clinical manifestations of AD, particularly its behavioral and psychological symptoms. This evidence concerns the gene NPBWR1 and Alzheimer disease.